Lineage Cell Therapeutics, Inc. (LCTX): Weighted Average Diluted Shares
230.12M
Year ended 2025-12-31
+10.7%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 230.12M | +14.9% | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | 200.19M | +15.9% | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | 172.66M | +1.7% | 2025-03-10, From 2023-01-01 |
| 2022-12-31 | 169.79M | n/c | 2024-03-07, From 2022-01-01 |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | 114.48M | +15.0% | 2018-03-15, From 2017-01-01 |
| 2016-12-31 | 99.55M | +24.9% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | 79.71M | +19.9% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | 66.47M | n/a | 2017-03-16, From 2014-01-01 |